KAMA 4ct Psuedoindoxyl Tabs Unflavored 50mg per Tablet

KAMA Pseudo Tablets 4ct – 200mg Total (50mg Pseudoindoxyl per Chewable Tablet) – Unflavored

KAMA Pseudo Tablets deliver a concentrated 50mg of pseudoindoxyl (a potent kratom-derived alkaloid form) per chewable tablet, crafted specifically for experienced adult users seeking standardized strength in a minimal, no-frills format. This 4 count pack (200mg total) offers a compact, travel-ready supply that removes the variability of loose plant material and the prep time of traditional methods. With an intentionally unflavored profile, you get a clean, straightforward experience—no sweeteners, no masking agents—ideal for users who value purity over taste additives.

The chewable delivery supports convenient, discreet use while emphasizing measured, deliberate intake. Each batch is third-party lab tested to verify identity, confirm labeled potency, and screen for common contaminants (e.g., heavy metals, microbial impurities, adulterants), reinforcing consistency from tablet to tablet. Intended benefits such as calm, centered focus, or mood lift should always be approached with caution; individual responses vary widely based on tolerance, physiology, and context.

Key Features:

• High-strength pseudoindoxyl: 50mg per chewable tablet (200mg total per 4ct pack)
• Unflavored: no added flavoring—clean, minimal formulation
• Designed for experienced, informed adult users (not a beginner product)
• Chewable format for portability and practical convenience
• Third-party lab tested for potency verification and purity assurance
• Standardized dosage—supports predictable planning compared to raw powder variability
• Discreet, no-mess alternative to traditional kratom preparations

Use & Responsibility: Follow on-package directions exactly. Because potency is concentrated, many experienced users opt to begin with less than a full unit to reassess tolerance before consuming additional product. Do not exceed the labeled maximum daily amount. Avoid combining with alcohol, sedatives, opioids, or other central nervous system depressants. Space any servings appropriately—stacking can increase risk of adverse effects.

Quality & Transparency: Each production lot undergoes independent laboratory analysis. Potency confirmation and contaminant screening (where applicable) support informed decision-making and align the product with its label claims. Reference batch or Certificate of Analysis (COA) data when available.

Safety & Caution: Not for individuals who are pregnant, nursing, under 21, or managing health conditions without professional guidance. Discontinue use and seek medical advice if unexpected effects (e.g., pronounced dizziness, nausea, excessive sedation) occur. Do not operate vehicles or heavy machinery if you feel impaired. Keep out of reach of children and pets.

Storage & Handling: Store sealed in a cool, dry location away from direct sunlight, heat, and moisture. Do not use if the package is damaged or tamper-evident features are compromised. Reseal or protect remaining tablets after opening to preserve integrity.

Disclaimer: Statements regarding this product have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use—especially if taking medications or evaluating possible interactions. Use only as directed and in compliance with applicable laws and regulations.

KAMA Pseudo Tablets (Unflavored) provide a stripped-down, lab-verified, high-strength chewable solution for seasoned users who prioritize purity, precision, and portability in a compact 4 count format.